My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.

    Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS; Bogalusa Heart Study.

    Diabetes. 2003 May;52(5):1265-9.PMID: 12716762 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.

    González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT.

    Eur J Endocrinol. 2002 Oct;147(4):495-501.PMID: 12370112 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G.

    Clin Endocrinol (Oxf). 2002 Oct;57(4):481-6.PMID: 12354130 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    6.

    PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.

    Buzzetti R, Petrone A, Caiazzo AM, Alemanno I, Zavarella S, Capizzi M, Mein CA, Osborn JA, Vania A, di Mario U.

    Pediatr Res. 2005 Jan;57(1):138-40. Epub 2004 Nov 5.PMID: 15531738 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.

    Chuang LM, Hsiung CA, Chen YD, Ho LT, Sheu WH, Pei D, Nakatsuka CH, Cox D, Pratt RE, Lei HH, Tai TY.

    J Mol Med. 2001 Nov;79(11):656-64.PMID: 11715069 [PubMed - indexed for MEDLINE]Related articles

    8.

    Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

    Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ.

    Metabolism. 2004 Jan;53(1):11-6.PMID: 14681835 [PubMed - indexed for MEDLINE]Related articles

    9.

    Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.

    Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clément K, Charles MA, Tauber M, Weill J, Froguel P.

    BMC Med Genet. 2005 Mar 22;6:11.PMID: 15784141 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.

    Stefan N, Fritsche A, Häring H, Stumvoll M.

    Diabetes. 2001 May;50(5):1143-8.PMID: 11334419 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.

    Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Di Mario U.

    Eur J Hum Genet. 2004 Dec;12(12):1050-4.PMID: 15367918 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.

    Jaziri R, Lobbens S, Aubert R, Péan F, Lahmidi S, Vaxillaire M, Porchay I, Bellili N, Tichet J, Balkau B, Froguel P, Marre M, Fumeron F; DESIR Study Group.

    Diabetes. 2006 Apr;55(4):1157-62.PMID: 16567542 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.

    Scaglioni S, Verduci E, Salvioni M, Biondi ML, Radaelli G, Agostoni C, Giovannini M.

    Pediatr Res. 2006 Oct;60(4):485-9. Epub 2006 Aug 28.PMID: 16940242 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    16.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.

    Rosmond R, Chagnon M, Bouchard C.

    Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):159-63.PMID: 12673785 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.

    Frederiksen L, Brødbaek K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA.

    J Clin Endocrinol Metab. 2002 Aug;87(8):3989-92.PMID: 12161548 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.

    Ylönen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C; Botnia Research Group.

    Eur J Clin Nutr. 2008 Dec;62(12):1432-9. Epub 2007 Aug 15.PMID: 17700648 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.

    Dongxia L, Qi H, Lisong L, Jincheng G.

    Circ J. 2008 Apr;72(4):551-7.PMID: 18362424 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity